Cameron Payne (Phoenix Suns) with a 3-pointer vs the Washington Wizards, 04/10/2021
Cameron Payne (Phoenix Suns) with a 3-pointer vs the Washington Wizards, 04/10/2021
The singer grew up in Suffolk and is a long-time supporter of the team.
The "Cystic Fibrosis - Disease Insights and Market Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering.
8x8, Inc. (NYSE: EGHT) announced the new 8x8 Voice for Microsoft Teams app adds SMS, MMS and fax features to extend the Teams experience for users
Vaccine Storage Equipment Market Research Report by Product (Freezer and Refrigerator), by Type (Refrigerated Storage and Refrigerated Transport), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, May 06, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Vaccine Storage Equipment Market Research Report by Product, by Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05911831/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Vaccine Storage Equipment Market is expected to grow from USD 890.45 Million in 2020 to USD 1,220.19 Million by the end of 2025.2. The Global Vaccine Storage Equipment Market is expected to grow from EUR 780.76 Million in 2020 to EUR 1,069.89 Million by the end of 2025.3. The Global Vaccine Storage Equipment Market is expected to grow from GBP 694.10 Million in 2020 to GBP 951.13 Million by the end of 2025.4. The Global Vaccine Storage Equipment Market is expected to grow from JPY 95,033.98 Million in 2020 to JPY 130,226.08 Million by the end of 2025.5. The Global Vaccine Storage Equipment Market is expected to grow from AUD 1,293.05 Million in 2020 to AUD 1,771.89 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Vaccine Storage Equipment to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Product, the Vaccine Storage Equipment Market studied across Freezer and Refrigerator. Based on Type, the Vaccine Storage Equipment Market studied across Refrigerated Storage and Refrigerated Transport. Based on End User, the Vaccine Storage Equipment Market studied across Clearing & Forwarding Agent, Distributor, and Retailer. Based on Geography, the Vaccine Storage Equipment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Storage Equipment Market including AmerisourceBergen Corporation, Arctiko, B Medical Systems S.à r.l., Biobase Biodusty(Shandong), Co., Ltd., C.F. di Ciro Fiocchetti & C. s.n.c., Cardinal Logistics Management Corporation, Cole-Parmer Instrument Company, LLC, DHL International GmbH, Dulas Ltd., Eppendorf AG, Evermed S.R.L., Haier Biomedical, Helmer Scientific Inc, Labcold Ltd, Labnet International Inc (Corning Incorporated), LINEAGE LOGISTICS HOLDING, LLC, PHC Holdings Corporation, Philipp Kirsch GmbH, Schenker AG, Standex International Corporation (American BioTech Supply ), Thermo Fisher Scientific, Inc., and Vestfrost Solutions. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Storage Equipment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Vaccine Storage Equipment Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccine Storage Equipment Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccine Storage Equipment Market?4. What is the competitive strategic window for opportunities in the Global Vaccine Storage Equipment Market?5. What are the technology trends and regulatory frameworks in the Global Vaccine Storage Equipment Market?6. What are the modes and strategic moves considered suitable for entering the Global Vaccine Storage Equipment Market?Read the full report: https://www.reportlinker.com/p05911831/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
While starring in films like “Selma” and “Lee Daniels' The Butler,” actor David Oyelowo discovered a new passion: directing. Oyelowo was inspired to step behind-the-camera after learning different nuances of the craft from respected directors like Ava DuVernay and Will Gluck. For years, Oyelowo picked their brains to feel confident enough to make a leap of his own.
Students who appeared for the examination can visit the official website www.lkouniv.ac.in to check their scorecards
Jaipur (Rajasthan) [India], May 6 (ANI): In the light of surge in coronavirus cases, a non-profit organization Narayan Seva Sansthan announced that they will be providing free 'Corona kits' to COVID-infected patients in Maharashtra, Andhra Pradesh, Rajasthan, and other states.
Pottery Barn Kids and Pottery Barn Teen, portfolio brands of Williams-Sonoma, Inc. (NYSE: WSM) ), the world’s largest digital-first, design-led and sustainable home retailer, today debut a collection of home furnishings in partnership with EttaVee, the vibrant brand created by artist and influencer Jessi Raulet. The ‘EttaVee x Pottery Barn Kids’ and ‘EttaVee x Pottery Barn Teen’ collaborations bring Jessi’s hand-painted animal prints, bold patterns, and signature use of colors to nursery décor, bedding, rugs, and decorative accessories.
This milestone culminates 10 years of research and development perfecting the Company's BioFarming technology Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that online sales of its flagship VINIA® product in the United States will commence at 8 A.M. Eastern Time on May 12, 2021, via its vinia.com website.This milestone represents a turning point for BioHarvest as it brings its flagship product to the ...
KELOWNA, British Columbia, May 06, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health solutions to address today’s medical mental health issues is pleased to announce that it has now launched the e-commerce portal selling Allied’s CBD products in the United States. All products and brands can be previewed at www.alliedcorpbrands.com. In addition to the launch of the e-commerce portal, Allied is working towards many multi-state distributor contracts to get these products onto shelves in bricks and mortar retail locations. With the launch of this e-commerce portal, Allied has now launched products under its three brands. At this point, all products are hemp derived CBD products. The three Allied brands encompass a military, athletic and anti-aging line of products. The products included under each respective brand are listed below. About the Allied Brands: About the TACTICAL RELIEF™ Brand (www.alliedcorpbrands.com)Tactical Relief™ is a patriotic brand under which health and wellness products are brought to market to serve veterans and first responders. The flagship product “Liberty” is a hemp derived CBD tincture for sale in the US. Additional products include Tactical Hydration, a CBD infused electrolyte replacement drink. Some of the Tactical Relief ™ products currently offered under this brand: Tactical Relief ™ Tactical Hydration – a CBD infused electrolyte replacement drink with sodium citrated electrolyte replacement in three refreshing flavors.Tactical Relief ™ Liberty – A mint and vanilla flavored 1000mg CBD tincture fortified with specific terpene profile.Tactical Relief ™ FIZZ Tablets – 35mg CBD fizz tablets for adding to your water bottle.Tactical Relief ™ Battle Balm – CBD roll on activity rub for aches and pains.Tactical Relief ™ Quick Hit – CBD gummies. About EQUILIBRIUM BIO™ Brand (www.alliedcorpbrands.com)Equilibrium Bio is a lifestyle brand that is focused on everything Athletic. From Crossfit workouts to Ironman races to general athletic consumers, Equilibrium Bio products are there with the athlete along the entire competitive journey. Hydration and recovery are the primary areas of focus for this brand and it’s products. Some of the Equilibrium Bio™ products currently offered under this brand: Equilibrium Bio™ - Hydrosport CBD Drink – a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement in three refreshing flavors.Equilibrium Bio™ Hydrosport Tincture – 1000mg CBD tincture fortified with specific terpene profile.Equilibrium Bio™ FIZZ Tablets – 35mg CBD fizz tab for adding to your water bottle.Equilibrium Bio™ Sport Rub – CBD post activity rub for aches and pains.Equilibrium Bio™ Quick Hit – CBD gummies with vitamin B12. About MaXXa™ Brand – (www.alliedcorpbrands.com)An aesthetically sleek brand that is focused on developing natural CBD infused cosmetics and beauty products. There are currently six unique products in the catalogue. These products are specifically targeted with beauty and anti-aging in mind. Some of the MaXXa™ products currently offered under this brand: MaXXa™ Skin Structure - Skin Structure is a facial formula topically applied to improve skin’s radiance and youthfulness.MaXXa™ Eye Recover - Eye Recover is based on antioxidant power of low molecular weight hyaluronic acid. Ultra-hydrating eye serum helps the delicate eye skin ward off free radicals as well as helping to protect against sun damage. MaXXa™ Glossy Lip Recover - Glossy Lip Recover moisturizes and nourishes the lips and gives them a silky smoothness. Enriched with rich fruit extracts - beeswax as well as oils and butter - this lip gloss moisturizes, beautifies and revitalises your lips.MaXXa™ Skin Designer – skin designer uplifts your skin with the power of CBD extracts and hyaluronic acid. This product stimulates cell regeneration while minimizing age spots.MaXXa™ Vitamin Absolute - Vitamin Absolute is a soothing, calming and all-around moisturizing facial oil. MaXXa™ Absolute Recover - this specialized formulation allows the infused bioactive compounds to be delivered directly to the desired areas of inflammation, pain and other skin ailments. “Creating a brand presence and launching products for sale in the United States is a key part of our business plan. Developing sales and distribution relationships while the US moves closer to national legalization of all cannabis products is a key part of Allied’s supply chain,” said Calum Hughes CEO of Allied. About Allied Corp. - https://allied.health/ Allied Corp. is an international heath company with a mission to address today’s medical issues by researching, creating and producing targeted health solutions. Allied Corp. uses an evidence-informed scientific approach to make this mission possible, through cutting-edge pharmaceutical research and development, innovative plant- and mushroom-based development of therapeutic products. Investor Relations:firstname.lastname@example.org Forward-Looking Statements:This press release contains “forward-looking information” within the meaning of applicable securities laws in Canada or “forward-looking statements” made pursuant to the “safe harbour” provisions of the United States Private Securities Litigation Reform Act of 1995 (collectively, “forward-looking information”). Forward-looking information may relate to the Company’s future outlook and anticipated events, plans or results, and may include information regarding the Company’s objectives, goals, strategies, future revenue or performance and capital expenditures, and other information that is not historical information. Forward-looking information can often be identified by the use of terminology such as “believe,” “anticipate,” “plan,” “expect,” “pending,” “in process,” “intend,” “estimate,” “project,” “may,” “will,” “should,” “would,” “could,” “can,” the negatives thereof, variations thereon and similar expressions. The forward-looking information contained in this press release is based on the Company’s opinions, estimates and assumptions in light of management’s experience and perception of historical trends, current conditions and expected future developments, as well as other factors that management currently believes are appropriate and reasonable in the circumstances. Forward looking statements in this press release include the following: that Allied is leveraging the conditions in its Colombia grow operation and future Kelowna location to support its Research and Development efforts; that Allied is making important strides forward to position itself as a leader in the medical cannabis space, that Allied intends to make a series of proposed trademark and other intellectual property protection filings, as part of the Company’s Intellectual Property and Pharma Development (IP&PD) Strategy, statements respecting the joint development, manufacturing, and introduction of TACTICAL RELIEF™ branded products, and the use of proceeds from the offering of convertible notes. There can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Risk factors that could cause actual results to differ materially from forward-looking information in this release include: the Company’s exposure to legal and regulatory risk; the effect of the legalization of adult-use cannabis in Canada and Colombia on the medical cannabis industry is unknown and may significantly and negatively affect the Company’s medical cannabis business; that the medical benefits, viability, safety, efficacy, dosing and social acceptance of cannabis are not as currently expected; that adverse changes or developments affecting the Company’s main or planned facilities may have an adverse effect on the Company; that the medical cannabis industry and market may not continue to exist or develop as anticipated or the Company may not be able to succeed in this market; risks related to completion of the greenhouse construction in Colombia, risks related to market competition; risks related to the proposed adult-use cannabis industry and market in Canada and Colombia including the Company’s ability to enter into or compete in such markets; that the Company has a limited operating history and a history of net losses and that it may not achieve or maintain profitability in the future; risks related to the Company’s current or proposed international operations; risks related to future third party strategic alliances or the expansion of currently existing relationships with third parties; that the Company may not be able to successfully identify and execute future acquisitions or dispositions or successfully manage the impacts of such transactions on its operations; risks inherent to the operation of an agricultural business; that the Company may be unable to attract, develop and retain key personnel; risks resulting from significant interruptions to the Company’s access to certain key inputs such as raw materials, electricity, water and other utilities; that the Company may be unable to transport its cannabis products to patients in a safe and efficient manner; risks related to recalls of the Company’s cannabis products or product liability or regulatory claims or actions involving the Company’s cannabis products; risks related to the Company’s reliance on pharmaceutical distributors; that the Company, or the cannabis industry more generally, may receive unfavourable publicity or become subject to negative consumer or investor perception; that certain events or developments in the cannabis industry more generally may impact the Company’s reputation or its relationships with customers or suppliers; that the Company may not be able to obtain adequate insurance coverage in respect of the risks that it faces, that the premiums for such insurance may not continue to be commercially justifiable or that there may be coverage limitations and other exclusions which may result in such insurance not being sufficient; that the Company may become subject to liability arising from fraudulent or illegal activity by its employees, contractors, consultants and others; that the Company may experience breaches of security at its facilities or losses as a result of the theft of its products; risks related to the Company’s information technology systems; that the Company may be unable to sustain its revenue growth and development; that the Company may be unable to expand its operations quickly enough to meet demand or manage its operations beyond their current scale; that the Company may be unable to secure adequate or reliable sources of necessary funding; risks related to, or associated with, the Company’s exposure to reporting requirements; risks related to conflicts of interest; risks related to fluctuations in foreign currency exchange rates; risks related to the Company’s potential exposure to greater-than-anticipated tax liabilities; risks related to the protection and enforcement of the Company’s intellectual property rights, or the intellectual property that it licenses from others; that the Company may become subject to allegations that it or its licensors are in violation of the intellectual property rights of third parties; that the Company may not realize the full benefit of the clinical trials or studies that it participates in; that the Company may not realize the full benefit of its licenses if the licensed material has less market appeal than expected and the licenses may not be profitable; as well as any other risks that may be further described in and the risk factors discussed in the Company's continuous disclosure including its Management's Discussion and Analysis sections in its Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K filed under the Company's profile at www.sec.gov. Although management has attempted to identify important risk factors that could cause actual results to differ materially from those contained in the forward-looking information in this presentation, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information in this presentation. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers and viewers should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this release represents the Company’s expectations as of the date of this release or the date indicated, regardless of the time of delivery of the presentation. The Company disclaims any intention, obligation or undertaking to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required under applicable securities laws.
Innovative ETF issuer, ETF Managers Group (ETFMG®), together with their partners at Breakwave Advisors LLC, an asset management and advisor services firm for the shipping and commodities industries, is happy to announce that the Breakwave Dry Bulk Shipping ETF (NYSE Arca: BDRY) has surpassed a significant milestone of $100 million in assets under management.* The first-to-market product, which debuted in 2018, remains the only freight futures ETF exclusively focused on dry bulk shipping, an instrumental part of the global commodity market.
Alaska Communications Systems Group, Inc. (NASDAQ: ALSK) today reported financial results for the first quarter of 2021.
Drivers stopped and the fight continued around them.
U.S. worker productivity rebounded in the first quarter, depressing labor costs growth, but the data has been severely distorted by the COVID-19 pandemic to provide a clear trend. The Labor Department said on Thursday that nonfarm productivity, which measures hourly output per worker, increased at a 5.4% annualized rate last quarter. Data for the fourth quarter was revised higher to show productivity falling at a 3.8% rate instead of the previously reported 4.2% pace.
WASHINGTON — U.S. productivity posted a sharp rebound between January and March after falling in the previous quarter. Labor costs declined slightly. Productivity increased at an annual rate of 5.4% in the first quarter, recovering from a 3.8% rate of decline in the fourth quarter of last year, the Labor Department reported Thursday. Labor costs fell at a 0.3% rate in the first quarter following a 5.6% jump in the fourth quarter. It was the biggest quarterly rise in productivity since an 11.2% surge in the second quarter of last year, a gain that reflected the fact that output was not falling as fast as the labour market was shrinking as millions of people were being laid off in the pandemic. Productivity is the amount of output per hour of work. The first quarter gain had been expected given that the gross domestic product, the country's total output of goods and services, had risen by a robust 6.4% rate in the first quarter. Martin Crutsinger, The Associated Press
Dunkin' and Chipotle are offering nurses and health care workers freebies for National Nurses Week, which kicks off Thursday with National Nurses Day.
Image source: Getty Images Today's mortgage rates are mixed compared to yesterday. Here's what they look like on May 6, 2021: Mortgage Type Today's Interest Rate 30-year fixed mortgage 3.
Dublin, May 06, 2021 (GLOBE NEWSWIRE) -- The "Herbal Supplements - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Herbal Supplements estimated at US$10.8 Billion in the year 2020, is projected to reach a revised size of US$16.9 Billion by 2027, growing at a CAGR of 6.6% over the analysis period 2020-2027. Echinacea, one of the segments analyzed in the report, is projected to record a 6.9% CAGR and reach US$6.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Flaxseeds segment is readjusted to a revised 6.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.9 Billion, While China is Forecast to Grow at 9.9% CAGRThe Herbal Supplements market in the U.S. is estimated at US$2.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2027 trailing a CAGR of 10% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.Turmeric Segment to Record 7% CAGRIn the global Turmeric segment, USA, Canada, Japan, China and Europe will drive the 6.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.6 Billion in the year 2020 will reach a projected size of US$2.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.3 Billion by the year 2027, while Latin America will expand at a 8.3% CAGR through the analysis period.Select Competitors (Total 36 Featured): Ancient GreenFields Pvt. Ltd.Archer Daniels Midland CompanyArizona Natural ProductsBio-Botanica Inc.BlackmoresGaia HerbsGlanbia plcHerbalife International of America, Inc.Jarrow Formulas, Inc.NaturaLife Asia Co., Ltd.Nature's BountyNBTY, Inc.Now FoodsNutraceutical International CorporationRicolaSolgar, Inc. Key Topics Covered: I. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Influencer Market InsightsWorld Market TrajectoriesImpact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS UNITED STATESCANADAJAPANCHINAEUROPEFRANCEGERMANYITALYUNITED KINGDOMSPAINRUSSIAREST OF EUROPEASIA-PACIFICAUSTRALIAINDIASOUTH KOREAREST OF ASIA-PACIFICLATIN AMERICAARGENTINABRAZILMEXICOREST OF LATIN AMERICAMIDDLE EASTIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTAFRICA IV. COMPETITION Total Companies Profiled: 36 For more information about this report visit https://www.researchandmarkets.com/r/nx4j8 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The National Black Bank Foundation announced Thursday the board appointments of King Center CEO Dr. Bernice A. King and actor Hill Harper.
Teknova appoints Matt Lowell as CFO